Date Name Title Filing Type Shares Traded Price Total Held
May 15, 2024
Director, Bd. Co-Chair, President & CEO
Director, Bd. Co-Chair, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 103 $986.57 397,786
May 15, 2024
Director, Bd. Co-Chair, President & CEO
Director, Bd. Co-Chair, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 281 $985.72 397,889
Dec 16, 2014
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 240,000 -- 398,079
May 15, 2024
Director, Bd. Co-Chair, President & CEO
Director, Bd. Co-Chair, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 305 $984.00 398,170
May 15, 2024
Director, Bd. Co-Chair, President & CEO
Director, Bd. Co-Chair, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 250 $983.91 398,475
May 15, 2024
Director, Bd. Co-Chair, President & CEO
Director, Bd. Co-Chair, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 235 $982.66 398,725
May 15, 2024
Director, Bd. Co-Chair, President & CEO
Director, Bd. Co-Chair, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 1,081 $981.50 398,960
May 21, 2020
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 8,359 $562.48 399,038
Jul 10, 2018
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 300 $371.29 399,847
Jun 21, 2018
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 200 $336.87 399,847

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.